Video Experimental Relacionado
Updated: Aug 19, 2026
10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
Tuberculosis en pacientes inmunodeprimidos
Lancet (London, England)
|June 2, 1979
Resumen
La tuberculosis puede desarrollarse en pacientes en terapia inmunosupresora a largo plazo, a menudo con diagnóstico tardío debido a síntomas suprimidos. El monitoreo vigilante y la investigación proactiva son cruciales para la detección temprana y los mejores resultados en estos pacientes vulnerables.
Área de la Ciencia:
- Inmunología Inmunología.
- Enfermedades infecciosas Enfermedades infecciosas.
- Pulmonología Pulmonología.
Sus antecedentes:
- La terapia inmunosupresora a largo plazo se utiliza para diversas afecciones.
- Los corticosteroides, particularmente la prednisolona, se usan con frecuencia en regímenes inmunosupresores.
- La inmunosupresión puede aumentar el riesgo de infecciones oportunistas como la tuberculosis.
Objetivo del estudio:
- Para describir casos de tuberculosis en pacientes que reciben terapia inmunosupresora a largo plazo.
- Para resaltar los desafíos de diagnóstico y los resultados en esta población de pacientes.
- Para enfatizar la necesidad de estrategias de gestión específicas.
Principales métodos:
- Una serie de casos retrospectivos de 11 pacientes.
- Revisión de los datos de los pacientes, incluidos los regímenes de medicamentos inmunosupresores, la presentación clínica, el diagnóstico y los resultados.
- Análisis de retrasos en el diagnóstico y respuestas al tratamiento.
Principales resultados:
- 11 pacientes desarrollaron tuberculosis durante la terapia inmunosupresora, principalmente con altas dosis de corticosteroides.
- El diagnóstico se retrasó en todos los casos debido a síntomas enmascarados.
- La mortalidad fue significativa (4 muertes), con 3 directamente debido a la tuberculosis.
- Los sobrevivientes tenían una gravedad variable, desde enfermedad crítica hasta enfermedad pulmonar avanzada con propagación militar.
Conclusiones:
- Un alto índice de sospecha de tuberculosis es esencial en pacientes en tratamiento inmunosupresor a largo plazo.
- Se recomienda un monitoreo clínico y radiológico regular.
- La investigación previa al tratamiento y la quimioprofilaxis potencial deben considerarse para los pacientes que inician un tratamiento inmunosupresor, especialmente con prednisolona.
Más Videos Relacionados
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Videos de Conceptos Relacionados
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:23Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...